2005 NEWS RELEASES
December 13, 2005 HUMAN GENOME SCIENCES ANNOUNCES DECISION TO SPIN OFF COGENESYS DIVISION AS AN INDEPENDENT COMPANY
December 13, 2005 HUMAN GENOME SCIENCES TO SPONSOR CONFERENCE CALL TO DISCUSS DECISION TO SPIN OFF COGENESYS DIVISION AS AN INDEPENDENT COMPANY
December 12, 2005 HUMAN GENOME SCIENCES REPORTS RESULTS OF PHASE 2 CLINICAL TRIAL OF HGS-ETR1 IN PATIENTS WITH ADVANCED NON-HODGKIN'S LYMPHOMA
December 1, 2005 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT FIRST ALBANY CONFERENCE
December 1, 2005HUMAN GENOME SCIENCES APPOINTS TUAN HA-NGOC TO ITS BOARD OF DIRECTORS
November 17, 2005 HUMAN GENOME SCIENCES REPORTS INTERIM RESULTS OF PHASE 1B CLINICAL TRIALS OF HGS-ETR1 IN COMBINATION WITH CHEMOTHERAPY IN PATIENTS WITH ADVANCED SOLID TUMORS
November 17, 2005 HUMAN GENOME SCIENCES REPORTS RESULTS OF PHASE 1 CLINICAL TRIALS OF HGS-ETR2 IN PATIENTS WITH ADVANCED SOLID TUMORS
November 17, 2005 HUMAN GENOME SCIENCES REPORTS PHASE 2 RESULTS FOR LYMPHOSTAT-B (BELIMUMAB) IN PATIENTS WITH RHEUMATOID ARTHRITIS
November 15, 2005HUMAN GENOME SCIENCES REPORTS INTERIM RESULTS OF PHASE 2 CLINICAL TRIAL OF ALBUFERON IN COMBINATION WITH RIBAVIRIN IN TREATMENT-EXPERIENCED HEPATITIS C PATIENTS
November 15, 2005 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT CREDIT SUISSE FIRST BOSTON CONFERENCE
November 8, 2005 HUMAN GENOME SCIENCES CALLS FOR REDEMPTION ALL OF ITS REMAINING OUTSTANDING SUBORDINATED NOTES DUE 2007
November 3, 2005 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT CIBC WORLD MARKETS CONFERENCE
November 1, 2005HUMAN GENOME SCIENCES REPORTS RESULTS OF PHASE 2 CLINICAL TRIAL OF HGS-ETR1 IN PATIENTS WITH ADVANCED COLORECTAL CANCER
October 25, 2005 HUMAN GENOME SCIENCES ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2005
October 25, 2005HUMAN GENOME SCIENCES COMPLETES PATIENT ENROLLMENT IN A PHASE 2B CLINICAL TRIAL OF ALBUFERON® IN COMBINATION WITH RIBAVIRIN IN TREATMENT-NAÏVE PATIENTS WITH CHRONIC HEPATITIS C
October 19, 2005 HUMAN GENOME SCIENCES ANNOUNCES COMPLETION OF REPURCHASE OF CONVERTIBLE SUBORDINATED NOTES
October 12, 2005HUMAN GENOME SCIENCES APPOINTS ROBERT C. YOUNG, M.D., TO ITS BOARD OF DIRECTORS
October 5, 2005 HUMAN GENOME SCIENCES TO SPONSOR CONFERENCE CALL TO DISCUSS PHASE 2 CLINICAL RESULTS OF LYMPHOSTAT-B IN SYSTEMIC LUPUS ERYTHEMATOUS PATIENTS
October 5, 2005 HUMAN GENOME SCIENCES REPORTS RESULTS OF A PHASE 2 CLINICAL TRIAL OF LYMPHOSTAT-B IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
October 3, 2005HUMAN GENOME SCIENCES AWARDED TWO-PHASE CONTRACT TO SUPPLY ABTHRAX FOR THE TREATMENT OF INHALATIONAL ANTHRAX DISEASE TO THE U.S. GOVERNMENT
September 22, 2005HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT UBS CONFERENCE
September 15, 2005 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT BANC OF AMERICA CONFERENCE
September 8, 2005 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT BEAR STEARNS CONFERENCE
September 6, 2005HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT BIOCENTURY CONFERENCE
September 2, 2005HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF DISCUSSION AT THOMAS WEISEL PARTNERS CONFERENCE
August 18, 2005 GLAXOSMITHKLINE EXERCISES OPTION TO HUMAN GENOME SCIENCES' TRAIL RECEPTOR ANTIBODY
August 9, 2005 HUMAN GENOME SCIENCES ANNOUNCES PRICING OF $230 MILLION PRIVATE PLACEMENT OF CONVERTIBLE SUBORDINATED NOTES
August 4, 2005 HUMAN GENOME SCIENCES ANNOUNCES PRICING OF $230 MILLION PRIVATE PLACEMENT OF CONVERTIBLE SUBORDINATED NOTES
August 3, 2005 HUMAN GENOME SCIENCES ANNOUNCES PROPOSED PRIVATE OFFERING OF CONVERTIBLE SUBORDINATED NOTES
August 1, 2005HUMAN GENOME SCIENCES RECEIVES MILESTONE PAYMENTS FROM GLAXOSMITHKLINE FOR GSK716155 PROGRESS
July 25, 2005HUMAN GENOME SCIENCES ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER OF 2005
July 22, 2005HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT BANC OF AMERICA CONFERENCE
July 18, 2005 HUMAN GENOME SCIENCES PUBLISHES RESULTS OF PHASE 1 CLINICAL TRIAL OF ABTHRAX FOR USE IN PREVENTION AND TREATMENT OF ANTHRAX INFECTION
July 14, 2005HUMAN GENOME SCIENCES NAMES BARRY A. LABINGER EXECUTIVE VICE PRESIDENT AND CHIEF COMMERCIAL OFFICER
July 7, 2005 GLAXOSMITHKLINE EXERCISES OPTION TO LYMPHOSTAT-B
July 5, 2005 HUMAN GENOME SCIENCES REPORTS RESULTS OF PHASE 2 CLINICAL TRIAL OF HGS-ETR1 IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
June 13, 2005HUMAN GENOME SCIENCES REPORTS INTERIM RESULTS OF PHASE 2 CLINICAL TRIAL OF HGS-ETR1 IN PATIENTS WITH ADVANCED NON-HODGKIN'S LYMPHOMA
June 13, 2005 HUMAN GENOME SCIENCES REPORTS INTERIM RESULTS OF PHASE 2 CLINICAL TRIAL OF HGS-ETR1 IN PATIENTS WITH ADVANCED NON-HODGIN'S LYMPHOMA
June 10, 2005 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT GOLDMAN SACHS CONFERENCE
June 1, 2005HUMAN GENOME SCIENCES INITIATES PHASE 2B CLINICAL TRIAL OF ALBUFERON® IN COMBINATION WITH RIBAVIRIN IN TREATMENT-NAÏVE PATIENTS WITH CHRONIC HEPATITIS C
May 26, 2005 HUMAN GENOME SCIENCES REPORTS ON PROGRESS TOWARD COMMERCIALIZATION
May 19, 2005 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT ANALYST & INVESTOR MEETING
May 17, 2005 HUMAN GENOME SCIENCES REPORTS RESULTS OF PHASE 1 CLINICAL TRIALS OF HGS-ETR2 AND HGS-ETR1 IN PATIENTS WITH ADVANCED SOLID TUMORS
May 17, 2005HUMAN GENOME SCIENCES REPORTS RESULTS OF PRECLINICAL STUDY COMPARING ANTI-VIRAL ACTIVITY OF ALBUFERON AND THREE OTHER FORMS OF INTERFERON ALPHA USED TO TREAT HEPATITIS C
May 12, 2005HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT BANC OF AMERICA CONFERENCE
May 6, 2005HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT ROBERT W. BAIRD GROWTH STOCK CONFERENCE
April 25, 2005 HUMAN GENOME SCIENCES ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER OF 2005
April 18, 2005 HUMAN GENOME SCIENCES REPORTS RESULTS OF PHASE 1 CLINICAL TRIAL OF HGS-ETR1 IN PATIENTS WITH ADVANCED SOLID TUMORS
April 14, 2005HUMAN GENOME SCIENCES REPORTS POSITIVE RESULTS OF PHASE 2 CLINICAL TRIAL OF ALBUFERON® IN TREATMENT-NAÏVE PATIENTS WITH CHRONIC HEPATITIS C
April 6, 2005 HUMAN GENOME SCIENCES REPORTS RESULTS OF A PHASE 2 CLINICAL TRIAL OF LYMPHOSTAT-B IN PATIENTS WITH RHEUMATOID ARTHRITIS
March 30, 2005 HUMAN GENOME SCIENCES BEGINS DOSING OF PATIENTS IN A PHASE 1 CLINICAL TRIAL OF CCR5 MAB IN PATIENTS INFECTED WITH HIV-1
March 28, 2005 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT LEHMAN BROTHERS' CONFERENCE
March 11, 2005HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT SG COWEN CONFERENCE
March 3, 2005 HUMAN GENOME SCIENCES COMPLETES PATIENT ENROLLMENT IN A PHASE 2 CLINICAL TRIAL OF HGS-ETR1 FOR THE TREATMENT OF NON-HODGKIN'S LYMPHOMA
February 25, 2005HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCASTS FROM TWO SECURITIES CONFERENCES
February 23, 2005HUMAN GENOME SCIENCES COMPLETES PATIENT ENROLLMENT IN A PHASE 2 CLINICAL TRIAL OF HGS-ETR1 FOR THE TREATMENT OF COLORECTAL CANCER
February 16, 2005 HUMAN GENOME SCIENCES COMPLETES ENROLLMENT IN A PHASE 2 CLINICAL TRIAL OF ALBUFERON IN TREATMENT-NAÏVE PATIENTS WITH CHRONIC HEPATITIS C
February 7, 2005HUMAN GENOME SCIENCES REPORTS FINANCIAL RESULTS FOR FULL YEAR AND FOURTH QUARTER 2004
January 20, 2005 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT PIPER JAFFRAY HEALTH CARE CONFERENCE
January 10, 2005 HUMAN GENOME SCIENCES REPORTS ON PROGRESS OF CLINICAL TRIALS AND ANNOUNCES GOALS FOR 2005 AT JPMORGAN HEALTHCARE CONFERENCE
January 10, 2005 HUMAN GENOME SCIENCES RECEIVES FDA CLEARANCE TO INITIATE CLINICAL DEVELOPMENT OF A NEW COMPOUND FOR THE TREATMENT OF HIV/AIDS
January 7, 2005 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT JPMORGAN HEALTHCARE CONFERENCE
